End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
01 1LORATADINE
02 1MECLIZINE HYDROCHLORIDE
03 1MELOXICAM
04 1VERSACLOZ
01 121530
02 176805
03 1200432
04 1203479
01 3No
02 1Yes
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Drug : VERSACLOZ
Dosage Form : SUSPENSION; ORAL
Application Number : 203479
Country : US
Patented : Yes
Drug : MELOXICAM
Dosage Form : SUSPENSION; ORAL
Application Number : 21530
Country : US
Patented : No
Drug : MECLIZINE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 200432
Country : US
Patented : No
Drug : LORATADINE
Dosage Form : SYRUP; ORAL
Application Number : 76805
Country : US
Patented : No
